Kelonia is a company working on genetic medicine, using their Kelonia Therapeutics Platform with iGPS® technology to efficiently deliver genetic cargo to desired tissues.

Kelonia

Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.

Venrock

Horizons Ventures

Alta Partners

Kelonia Therapeutics

Last month, we had the privilege of hosting Dr. Kristen Hege, Kelonia board member and trailblazer in the field of cell therapy, for an inspiring leadership talk!
 
Dr. Hege shared profound insights from her journey hiking the Pacific Coast Trail, drawing compelling parallels to her pioneering work in CAR T-cell therapies. Her reflections on leadership, perseverance, and embracing challenges left a lasting impact on all who attended and continues to resonate with our team as we continue our work advancing our own lead in vivo CAR T program to the clinic.

We had a blast partnering with teammates from Special Olympics Massachusetts at last week’s Bio-Ball 2024 fundraiser and basketball tournament. We came together to #playunified and raise money for a great cause alongside our biotech industry peers. Team Kelonia proudly raised $16,378 for Special Olympics Massachusetts, putting us in 3rd place in the fundraising challenge, and securing our chance to play on the parquet floor at TD Garden with our teammates from Special Olympics Lynn & Haverill!  
 
Learn more about how you can support: https://lnkd.in/gBB2QkVP.  #ChooseToInclude #PlayUnified

We look forward to presenting preclinical data from our lead #invivo #CART candidate, KLN-1010, in #MultipleMyeloma at the American Association for Cancer Research Annual Meeting 2024 in San Diego. Stop by our poster presentation to learn more about the therapeutic potential of KLN-1010 and the promise of our iGPS® technology for #geneticmedicines.  
 
See details of our poster here: https://lnkd.in/gYq-Pz6f 
 
#AACR24

Our #2023HolidayParty was last week, after the holidays! This not only gave us something to look forward to in January, but it also allowed us to really let our hair down because it's a (slightly) less hectic time than the holidays. Congratulations to Jose Sanabria and Joshua Daniel, the winners of our ugly sweater contests!  Huge thanks to our neighbors, Capo Restaurant & Supper Club, for hosting us! It was a beautiful location with delicious food, and we had a great time!

Our Vice President, Strategy and Business Development, Bharat Reddy, is attending Biotechnology Innovation Organization’s #BIO2024. Connect with us in sunny San Diego, to learn more about our iGPS® platform exciting work advancing #invivo CAR-T therapies for cancer: https://lnkd.in/eEDtKaAK.

#HappyNewYear! We kicked off 2024 by bringing donations from our 2nd annual clothing drive to St. Francis House. Please consider donating new or gently-used clothes to your local shelter (especially outerwear!) to help your unhoused neighbors keep warm during these cold winter months.

KELO

COM:KELONIATX

Kelonia